Benzinga | Nov 8, 2021 07:14AM EST

JMP Securities Maintains Market Outperform on Enanta Pharmaceuticals, Raises Price Target to $121

JMP Securities analyst Jason Butler maintains Enanta Pharmaceuticals (NASDAQ:ENTA) with a Market Outperform and raises the price target from $77 to $121.